0.05Open0.05Pre Close18 Volume958 Open Interest7.50Strike Price90.00Turnover154.17%IV27.88%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier6DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0508Delta0.0483Gamma206.60Leverage Ratio-0.0158Theta-0.0001Rho-10.50Eff Leverage0.0015Vega
EyePoint Pharmaceuticals Stock Discussion
NEWS
EyePoint Pharmaceuticals Trial of Duravyu in Diabetic Eye Disease Fails to Meet Primary Endpoint
Larger Image: tradingview.com...
$EyePoint Pharmaceuticals(EYPT.US)$
$EyePoint Pharmaceuticals(EYPT.US)$
$Adverum Biotechnologies(ADVM.US)$
$Regenxbio(RGNX.US)$
$4D Molecular Therapeutics(FDMT.US)$
$Kodiak Sciences(KOD.US)$
📊⚡️📊
No comment yet